Old Web
English
Sign In
Acemap
>
authorDetail
>
Rongzhe Liu
Rongzhe Liu
Medicine
budget impact
Emergency medicine
Oncology
cost effectiveness
7
Papers
5
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Budget Impact Analysis of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Event.
2021
Advances in Therapy
Adnan Alsumali
Dominik Lautsch
Rongzhe Liu
Dipen Patel
Sakina Nanji
Laurence M. Djatche
Show All
Source
Cite
Save
Citations (1)
Cost effectiveness of axicabtagene ciloleucel versus tisagenlecleucel for adult patients with relapsed or refractory large B-cell lymphoma after 2 or more lines of systemic therapy in the United States.
2021
Journal of Medical Economics
Rongzhe Liu
Olalekan O. Oluwole
Ibrahim Diakite
Marc F. Botteman
Julia Thornton Snider
Frederick L. Locke
Show All
Source
Cite
Save
Citations (0)
Does Biosimilar Bevacizumab Offer Affordable Treatment Options for Cancer Patients in the USA? A Budget Impact Analysis from US Commercial and Medicare Payer Perspectives.
2021
Applied Health Economics and Health Policy
Jingyan Yang
Rongzhe Liu
V. Ektare
Jennifer Stephens
A. Shelbaya
Show All
Source
Cite
Save
Citations (3)
Biosimilar pegfilgrastim may offer affordable treatment options for patients in France: A budget impact analysis on the basis of clinical trial and real-world data.
2021
Journal of Medical Economics
Jingyan Yang
Rongzhe Liu
Anna Granghaud
Omer Zaidi
Jennifer Stephens
Show All
Source
Cite
Save
Citations (1)
Efficacy and safety of zanubrutinib versus rituximab-based chemoimmunotherapy in Waldenström macroglobulinemia (WM): Matching-adjusted indirect comparisons.
2021
Journal of Clinical Oncology
Jorge J. Castillo
Keri Yang
Rongzhe Liu
Yu Wang
Aileen Cohen
Todd M. Zimmerman
Qian Zhao
Xin Gao
Boxiong Tang
Show All
Source
Cite
Save
Citations (0)
1